The global market for clinical trial management systems was valued to be $1,152m in 2019 and is valued to reach $4,805.6m by 2030.

How this report will benefit you
  • Read on to discover how you can exploit the future business opportunities emerging in this sector.
  • In this brand new 360-page report you will receive 355-charts– all unavailable elsewhere.
  • The 360-page report provides clear detailed insight into the Global Clinical Trials Management System market, Discover the key drivers and challenges affecting the market.
  • By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
Global Clinical Trials Management Systems submarket forecasts from 2020-2030 covering:
  • Type
  • Component
  • Delivery Mode
  • End users
Global Clinical Trials Management Systems regional and national market forecasts from 2020-2030 covering:
  • North America: US, Canada
  • Europe: Germany, France, Italy, Spain, UK, Rest of Europe
  • Asia-Pacific: Japan, China, India, ASEAN, Rest of Asia Pacific
  • Latin America: Brazil, Mexico, Rest of Latin America
  • Middle East & Africa: GCC, South Africa, Rest of Middle East and Africa
Profiles of the leading Clinical Trials Management Systems companies
  • Acorn AI
  • Centra Health
  • Dassault Systemes
  • DSG Inc
  • DataTRAK Internationals, Inc
  • Datavant
  • ERT Clinical
  • Guerbet
  • IBM
  • OmniComm Systems
  • And many others
The content of each profile differs, depending on the organization. In general, a profile gives the following information:
  • An overview and analysis of the company
  • A portfolio of the company’s marketed product and product pipeline
  • Financial Information
  • Revenue forecast from 2020 – 2030
  • Recent developments
  • Future Outlook
This report discusses factors that drive and restrain the Global Clinical Trials Management System market forecast.